help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tonacchera, M.
Right arrow Articles by Parma, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tonacchera, M.
Right arrow Articles by Parma, J.

Journal of Clinical Endocrinology & Metabolism, Vol 81, 547-554, Copyright © 1996 by Endocrine Society


ARTICLES

Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia

M Tonacchera, J Van Sande, F Cetani, S Swillens, C Schvartz, P Winiszewski, L Portmann, JE Dumont, G Vassart and J Parma
Institut de Recherche Interdisciplinaire, Faculte de Medecine, Universite Libre de Bruxelles, Belgium.

We report three unrelated families in which hyperthyroidism associated with thyroid hyperplasia was transmitted in an autosomal dominant fashion, in the absence of signs of autoimmunity. Exon 10 of the TSH receptor gene was directly sequenced after PCR amplification from DNA of peripheral leukocytes. In one family, a C to A transversion resulted in an S505R substitution in the third transmembrane segment; in the second, an A to T transversion caused a N650Y substitution in the sixth transmembrane segment; and in the third family, an A to G transition resulted in an N670S substitution in the seventh transmembrane segment. When expressed by transfection in COS-7 cells, each mutated receptor displayed an increase in constitutive stimulation of cAMP production; no effect on basal accumulation of inositol phosphates (IP) could be detected. In binding studies, cells transfected with wild-type or mutated receptors showed similar levels of expression, with the mutated receptors displaying similar or slightly increased affinity for bovine TSH (bTSH) binding. Cells transfected with S505R and N650Y mutants showed a similar cAMP maximal TSH-stimulated accumulation over the cells transfected with the wild type, whereas N670S transfectants showed a blunted response with an increase in EC50. A higher IP response to 100 mU/mL bTSH over that obtained with the wild-type receptor was obtained in cells transfected with N650Y; in contrast, cells transfected with S505R showed a blunted IP production (50% less), and the N670S mutant completely lost the ability to stimulate IP accumulation in response to bTSH. The differential effects of individual mutations on stimulation by bTSH of cAMP or IP accumulation suggest that individual mutant receptors may achieve different active conformations with selective abilities to couple to Gs alpha and to Gq alpha.


This article has been cited by other articles:


Home page
FASEB J.Home page
G. Kleinau, H. Jaeschke, S. Mueller, B. M. Raaka, S. Neumann, R. Paschke, and G. Krause
Evidence for cooperative signal triggering at the extracellular loops of the TSH receptor
FASEB J, August 1, 2008; 22(8): 2798 - 2808.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
G. Kleinau, M. Brehm, U. Wiedemann, D. Labudde, U. Leser, and G. Krause
Implications for Molecular Mechanisms of Glycoprotein Hormone Receptors Using a New Sequence-Structure-Function Analysis Resource
Mol. Endocrinol., February 1, 2007; 21(2): 574 - 580.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Kleinau, M. Claus, H. Jaeschke, S. Mueller, S. Neumann, R. Paschke, and G. Krause
Contacts between Extracellular Loop Two and Transmembrane Helix Six Determine Basal Activity of the Thyroid-stimulating Hormone Receptor
J. Biol. Chem., January 5, 2007; 282(1): 518 - 525.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. Van Durme, F. Horn, S. Costagliola, G. Vriend, and G. Vassart
GRIS: Glycoprotein-Hormone Receptor Information System
Mol. Endocrinol., September 1, 2006; 20(9): 2247 - 2255.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
U. Ringkananont, J. Van Durme, L. Montanelli, F. Ugrasbul, Y. M. Yu, R. E. Weiss, S. Refetoff, and H. Grasberger
Repulsive Separation of the Cytoplasmic Ends of Transmembrane Helices 3 and 6 Is Linked to Receptor Activation in a Novel Thyrotropin Receptor Mutant (M626I)
Mol. Endocrinol., April 1, 2006; 20(4): 893 - 903.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Claus, H. Jaeschke, G. Kleinau, S. Neumann, G. Krause, and R. Paschke
A Hydrophobic Cluster in the Center of the Third Extracellular Loop Is Important for Thyrotropin Receptor Signaling
Endocrinology, December 1, 2005; 146(12): 5197 - 5203.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
S G Watson, A D Radford, A Kipar, P Ibarrola, and L Blackwood
Somatic mutations of the thyroid-stimulating hormone receptor gene in feline hyperthyroidism: parallels with human hyperthyroidism
J. Endocrinol., September 1, 2005; 186(3): 523 - 537.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
B. Karges, G. Krause, J. Homoki, K.-M. Debatin, N. de Roux, and W. Karges
TSH receptor mutation V509A causes familial hyperthyroidism by release of interhelical constraints between transmembrane helices TMH3 and TMH5
J. Endocrinol., August 1, 2005; 186(2): 377 - 385.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
S. Neumann, M. Claus, and R. Paschke
Interactions between the extracellular domain and the extracellular loops as well as the 6th transmembrane domain are necessary for TSH receptor activation
Eur. J. Endocrinol., April 1, 2005; 152(4): 625 - 634.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
L. Montanelli, J. J. J. Van Durme, G. Smits, M. Bonomi, P. Rodien, E. J. Devor, K. Moffat-Wilson, L. Pardo, G. Vassart, and S. Costagliola
Modulation of Ligand Selectivity Associated with Activation of the Transmembrane Region of the Human Follitropin Receptor
Mol. Endocrinol., August 1, 2004; 18(8): 2061 - 2073.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
O. Kifor, F. D. Moore Jr., M. Delaney, J. Garber, G. N. Hendy, R. Butters, P. Gao, T. L. Cantor, I. Kifor, E. M. Brown, et al.
A Syndrome of Hypocalciuric Hypercalcemia Caused by Autoantibodies Directed at the Calcium-Sensing Receptor
J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 60 - 72.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. W. Szkudlinski, V. Fremont, C. Ronin, and B. D. Weintraub
Thyroid-Stimulating Hormone and Thyroid-Stimulating Hormone Receptor Structure-Function Relationships
Physiol Rev, April 1, 2002; 82(2): 473 - 502.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Biebermann, T. Schoneberg, C. Hess, J. Germak, T. Gudermann, and A. Gruters
The First Activating TSH Receptor Mutation in Transmembrane Domain 1 Identified in a Family with Nonautoimmune Hyperthyroidism
J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4429 - 4433.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Tonacchera, P. Agretti, G. De Marco, A. Perri, A. Pinchera, P. Vitti, and L. Chiovato
Thyroid Resistance to TSH Complicated by Autoimmune Thyroiditis
J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4543 - 4546.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Neumann, G. Krause, S. Chey, and R. Paschke
A Free Carboxylate Oxygen in the Side Chain of Position 674 in Transmembrane Domain 7 Is Necessary for TSH Receptor Activation
Mol. Endocrinol., August 1, 2001; 15(8): 1294 - 1305.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. C. Ho, J. Van Sande, A. Lefort, G. Vassart, and S. Costagliola
Effects of Mutations Involving the Highly Conserved S281HCC Motif in the Extracellular Domain of the Thyrotropin (TSH) Receptor on TSH Binding and Constitutive Activity
Endocrinology, July 1, 2001; 142(7): 2760 - 2767.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Y.-X. Tao, A. N. Abell, X. Liu, K. Nakamura, and D. L. Segaloff
Constitutive Activation of G Protein-Coupled Receptors as a Result of Selective Substitution of a Conserved Leucine Residue in Transmembrane Helix III
Mol. Endocrinol., August 1, 2000; 14(8): 1272 - 1282.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Pohlenz, L. Duprez, R. E. Weiss, G. Vassart, S. Refetoff, and S. Costagliola
Failure of Membrane Targeting Causes the Functional Defect of Two Mutant Sodium Iodide Symporters
J. Clin. Endocrinol. Metab., July 1, 2000; 85(7): 2366 - 2369.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Tonacchera, P. Agretti, A. Pinchera, V. Rosellini, A. Perri, P. Collecchi, P. Vitti, and L. Chiovato
Congenital Hypothyroidism with Impaired Thyroid Response to Thyrotropin (TSH) and Absent Circulating Thyroglobulin: Evidence for a New Inactivating Mutation of the TSH Receptor Gene
J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1001 - 1008.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
S. J. Marx
CLINICAL REVIEW 109: Contrasting Paradigms for Hereditary Hyperfunction of Endocrine Cells
J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3001 - 3009.
[Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
E. M. Gabriel, E. R. Bergert, C. S. Grant, J. A. van Heerden, G. B. Thompson, and J. C. Morris
Germline Polymorphism of Codon 727 of Human Thyroid-Stimulating Hormone Receptor Is Associated with Toxic Multinodular Goiter
J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3328 - 3335.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
D. H. C. Khoo, J. Parma, C. Rajasoorya, S. C. Ho, and G. Vassart
A Germline Mutation of the Thyrotropin Receptor Gene Associated with Thyrotoxicosis and Mitral Valve Prolapse in a Chinese Family
J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1459 - 1462.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Grüters, T. Schöneberg, H. Biebermann, H. Krude, H. P. Krohn, H. Dralle, and T. Gudermann
Severe Congenital Hyperthyroidism Caused by a Germ-Line neo Mutation in the Extracellular Portion of the Thyrotropin Receptor
J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1431 - 1436.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
S. Kosugi, T. Mori, and A. Shenker
An Anionic Residue at Position 564 Is Important for Maintaining the Inactive Conformation of the Human Lutropin/Choriogonadotropin Receptor
Mol. Pharmacol., May 1, 1998; 53(5): 894 - 901.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
P. Wonerow, T. Schoneberg, G. Schultz, T. Gudermann, and R. Paschke
Deletions in the Third Intracellular Loop of the Thyrotropin Receptor. A NEW MECHANISM FOR CONSTITUTIVE ACTIVATION
J. Biol. Chem., April 3, 1998; 273(14): 7900 - 7905.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Tonacchera, L. Chiovato, A. Pinchera, P. Agretti, E. Fiore, F. Cetani, R. Rocchi, P. Viacava, P. Miccoli, and P. Vitti
Hyperfunctioning Thyroid Nodules in Toxic Multinodular Goiter Share Activating Thyrotropin Receptor Mutations with Solitary Toxic Adenoma
J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 492 - 498.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
P. J. Fuller, K. Verity, Y. Shen, P. Mamers, T. Jobling, and H. G. Burger
No Evidence of a Role for Mutations or Polymorphisms of the Follicle-Stimulating Hormone Receptor in Ovarian Granulosa Cell Tumors
J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 274 - 279.
[Abstract] [Full Text]


Home page
NEJMHome page
R. Paschke and M. Ludgate
The Thyrotropin Receptor in Thyroid Diseases
N. Engl. J. Med., December 4, 1997; 337(23): 1675 - 1681.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. A. Levine and M. D. Ringel
Resistance to TSH in Patients with Normal TSH Receptors--Where Do We Turn When "Sutton's Law" Proves False?
J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 3930 - 3932.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H.-P. Holzapfel, D. Fuhrer, P. Wonerow, G. Weinland, W. A. Scherbaum, and R. Paschke
Identification of Constitutively Activating Somatic Thyrotropin Receptor Mutations in a Subset of Toxic Multinodular Goiters
J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4229 - 4233.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. Fuhrer, P. Wonerow, H. Willgerodt, and R. Paschke
Identification of a New Thyrotropin Receptor Germline Mutation (Leu629Phe) in a Family with Neonatal Onset of Autosomal Dominant Nonautoimmune Hyperthyroidism
J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4234 - 4238.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H.-P. Holzapfel, P. Wonerow, W. von Petrykowski, M. Henschen, W. A. Scherbaum, and R. Paschke
Sporadic Congenital Hyperthyroidism due to a Spontaneous Germline Mutation in the Thyrotropin Receptor Gene
J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3879 - 3884.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. Fuhrer, H.-P. Holzapfel, P. Wonerow, W. A. Scherbaum, and R. Paschke
Somatic Mutations in the Thyrotropin Receptor Gene and Not in the Gs{alpha} Protein Gene in 31 Toxic Thyroid Nodules
J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3885 - 3891.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Parma, L. Duprez, J. Van Sande, J. Hermans, P. Rocmans, G. Van Vliet, S. Costagliola, P. Rodien, J. E. Dumont, and G. Vassart
Diversity and Prevalence of Somatic Mutations in the Thyrotropin Receptor and Gs{alpha} Genes as a Cause of Toxic Thyroid Adenomas
J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2695 - 2701.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Esapa, S. Foster, S. Johnson, J. L. Jameson, P. Kendall-Taylor, and P. E. Harris
G Protein and Thyrotropin Receptor Mutations in Thyroid Neoplasia
J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 493 - 496.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Kosugi, T. Mori, and A. Shenker
The Role of Asp578 in Maintaining the Inactive Conformation of the Human Lutropin/Choriogonadotropin Receptor
J. Biol. Chem., December 13, 1996; 271(50): 31813 - 31817.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Govaerts, A. Lefort, S. Costagliola, S. J. Wodak, J. A. Ballesteros, J. Van Sande, L. Pardo, and G. Vassart
A Conserved Asn in Transmembrane Helix 7 Is an On/Off Switch in the Activation of the Thyrotropin Receptor
J. Biol. Chem., June 15, 2001; 276(25): 22991 - 22999.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society